pazopanib

  post date: dec 29,2021   expiry date: jun 27,2022   detailed description: cas no. :444731-52-6 quantity: 100kilograms specs:99% payment method: t/t l/c product name:pazopanibsynonyms:pazopanib for research;5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;pazopanib;pazopanib(gw786034);5-(4-((2,3-dimethyl-3,3a-dihydro-2h-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide;5-[(4-{[(2,3-dimethyl-2h-indazol-6-yl)methyl]amino}pyrimidin-2-yl)amino]-2-methylbenzene-1-sulfonamide;5-({4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide 5-(4-(n-(2,3-dimethyl-2h-indazole-6-yl)- n-methylamino)pyrimidine-2-ylamino)-2-methylbenzenesulfonamide;votrientcas:444731-52-6mf:c21h23n7o2smw:437.52   cas registry number: 444731-52-6   synonyms: ;5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;5-({4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide;5-({4-[(2,3-dimethyl-2h-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride (1:1);   molecular formula: c21h24cln7o2s   molecular weight: 473.979   molecular structure: